We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
S icon
51
SentinelOne
S
$6.32B
$5.68M 0.4%
312,289
+290,401
+1,327% +$6.3M
RBLX icon
52
Roblox
RBLX
$35.7B
$5.66M 0.4%
97,112
-53,086
-35% -$3.34M
CRDO icon
53
Credo Technology Group
CRDO
$36.3B
$5.63M 0.4%
140,122
+43,214
+45% +$2.69M
EXPE icon
54
Expedia Group
EXPE
$35B
$5.57M 0.4%
33,140
+6,853
+26% +$1.25M
TVTX icon
55
Travere Therapeutics
TVTX
$5.18B
$5.55M 0.39%
309,534
+62,425
+25% +$1.27M
FRPT icon
56
Freshpet
FRPT
$3.04B
$5.47M 0.39%
65,761
+56,705
+626% +$6.94M
RYTM icon
57
Rhythm Pharmaceuticals
RYTM
$7.38B
$5.41M 0.38%
102,195
+58,612
+134% +$3.25M
BMRN icon
58
BioMarin Pharmaceuticals
BMRN
$12B
$5.36M 0.38%
75,876
-12,787
-14% -$860K
CAH icon
59
Cardinal Health
CAH
$54.2B
$5.32M 0.38%
38,592
-2,608
-6% -$332K
DVA icon
60
DaVita
DVA
$15.4B
$5.28M 0.38%
34,535
+11,455
+50% +$1.8M
CRS icon
61
Carpenter Technology
CRS
$27.7B
$5.28M 0.37%
29,115
+19,400
+200% +$3.74M
ECL icon
62
Ecolab
ECL
$79.2B
$5.27M 0.37%
20,793
+4,842
+30% +$1.22M
FSV icon
63
FirstService
FSV
$6.58B
$5.27M 0.37%
31,738
+12,012
+61% +$2.1M
OSIS icon
64
OSI Systems
OSIS
$3.62B
$5.25M 0.37%
26,996
+22,795
+543% +$4.34M
KMI icon
65
Kinder Morgan
KMI
$70.7B
$5.14M 0.37%
180,300
PCRX icon
66
Pacira BioSciences
PCRX
$1.05B
$5.14M 0.37%
206,992
-41,615
-17% -$996K
ATI icon
67
ATI
ATI
$25.4B
$5.12M 0.36%
98,362
+13,100
+15% +$744K
VITL icon
68
Vital Farms
VITL
$595M
$5.1M 0.36%
167,232
+101,011
+153% +$3.63M
TRUP icon
69
Trupanion
TRUP
$1.12B
$5.07M 0.36%
136,110
+105,605
+346% +$4.39M
AER icon
70
AerCap
AER
$24.1B
$5.04M 0.36%
49,292
+31,081
+171% +$3.08M
PSN icon
71
Parsons
PSN
$6.64B
$5.03M 0.36%
85,003
+54,012
+174% +$3.91M
ARQT icon
72
Arcutis Biotherapeutics
ARQT
$3.53B
$4.97M 0.35%
317,465
-2,250
-0.7% -$31.7K
GEV icon
73
GE Vernova
GEV
$250B
$4.82M 0.34%
15,784
-216
-1% -$75.3K
TFII icon
74
TFI International
TFII
$12.5B
$4.78M 0.34%
61,714
+48,497
+367% +$5.37M
MMYT icon
75
MakeMyTrip
MMYT
$5.11B
$4.77M 0.34%
48,651
+24,321
+100% +$2.51M

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.